ATE302018T1 - Gonadotropin releasing hormon antagonist - Google Patents

Gonadotropin releasing hormon antagonist

Info

Publication number
ATE302018T1
ATE302018T1 AT98938613T AT98938613T ATE302018T1 AT E302018 T1 ATE302018 T1 AT E302018T1 AT 98938613 T AT98938613 T AT 98938613T AT 98938613 T AT98938613 T AT 98938613T AT E302018 T1 ATE302018 T1 AT E302018T1
Authority
AT
Austria
Prior art keywords
releasing hormone
gonadotropin releasing
hormone antagonist
surge
premature
Prior art date
Application number
AT98938613T
Other languages
English (en)
Inventor
Bernadette Maria Jul Mannaerts
Bennink Herman Jan Ti Coelingh
Everardus Otto Maria Orlemans
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8228463&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE302018(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE302018T1 publication Critical patent/ATE302018T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/09Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98938613T 1997-06-20 1998-06-16 Gonadotropin releasing hormon antagonist ATE302018T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201885 1997-06-20
PCT/EP1998/003713 WO1998058657A1 (en) 1997-06-20 1998-06-16 Gonadotropin releasing hormone antagonist

Publications (1)

Publication Number Publication Date
ATE302018T1 true ATE302018T1 (de) 2005-09-15

Family

ID=8228463

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98938613T ATE302018T1 (de) 1997-06-20 1998-06-16 Gonadotropin releasing hormon antagonist

Country Status (8)

Country Link
US (1) US6653286B1 (de)
EP (1) EP0994718B1 (de)
AT (1) ATE302018T1 (de)
AU (1) AU8727798A (de)
DE (1) DE69831241T2 (de)
DK (1) DK0994718T3 (de)
ES (1) ES2247710T3 (de)
WO (1) WO1998058657A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1140132A1 (de) * 1999-06-23 2001-10-10 Akzo Nobel N.V. Gonadotropin freisetzungshormon antagonist
US20030092628A1 (en) * 1999-06-23 2003-05-15 De Greef Henrik Johan Matthieu Maria Gonadotropin releasing hormone antagonist
EA010354B1 (ru) * 2001-04-17 2008-08-29 Арес Трейдинг С.А. Ингибирование ароматазы для улучшения вспомогательной репродукции
US8048869B2 (en) 2001-05-18 2011-11-01 Pantarhei Bioscience B.V. Pharmaceutical composition for use in hormone replacement therapy
PT1390042E (pt) 2001-05-23 2008-03-10 Pantarhei Bioscience Bv Sistema de administração de um medicamento que compreende estrogénio tetrahidroxilado destinado à contracepção hormonal
ATE449606T1 (de) 2001-05-23 2009-12-15 Pantarhei Bioscience Bv Tetrahydroxylierte estrogen enthaltendes arzneistoffverabreichungssystem zur verwendung in hormonalen kontrazeption
KR20040032954A (ko) * 2001-09-12 2004-04-17 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 과배란 유도에서 hCG의 용도
IL160782A0 (en) * 2001-09-12 2004-08-31 Applied Research Systems USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT
EP1446128B1 (de) 2001-11-15 2006-12-06 Pantarhei Bioscience B.V. Verwendung von öestrogen in kombination mit progestogen für die hormonsubstitutions-therapie
CN1684737A (zh) * 2002-06-07 2005-10-19 阿雷斯贸易股份有限公司 控制性超排卵方法及该方法使用的药物试剂盒
CN1691947B (zh) 2002-06-11 2011-11-23 潘塔希生物科学股份有限公司 雌激素成分在制备用于治疗或预防免疫介导的疾病中的应用以及包含所述雌激素成分的药物组合物
US7943604B2 (en) 2002-06-11 2011-05-17 Pantarhei Bioscience B.V. Method of treating human skin and a skin care composition for use in such a method
ATE382356T1 (de) 2002-07-12 2008-01-15 Pantarhei Bioscience Bv Pharmazeutische zusammensetzung enthaltend estetrolderivate und anwendung in der krebsbehandlung
DK1556058T3 (da) 2002-10-23 2008-03-03 Pantarhei Bioscience Bv Farmaceutiske præparater omfattende östetrolderivater til anvendelse i cancerterapi
UA88879C2 (en) * 2003-09-02 2009-12-10 Эплайд Рисерч Системз Эрс Холдинг Н.В. Fsh glycosylation mutant
US8236785B2 (en) * 2007-01-08 2012-08-07 Pantarhei Bioscience B.V. Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists

Also Published As

Publication number Publication date
EP0994718B1 (de) 2005-08-17
EP0994718A1 (de) 2000-04-26
DE69831241T2 (de) 2006-03-23
ES2247710T3 (es) 2006-03-01
DE69831241D1 (de) 2005-09-22
AU8727798A (en) 1999-01-04
US6653286B1 (en) 2003-11-25
WO1998058657A1 (en) 1998-12-30
DK0994718T3 (da) 2005-12-19

Similar Documents

Publication Publication Date Title
ATE302018T1 (de) Gonadotropin releasing hormon antagonist
DE69620241D1 (de) Gonadotropin releasing hormon- antagonisten
MX9804850A (es) Antagonistas de hormona liberadora de gonadotropina.
LT96133A (en) Remedy for treatment of ovarian estrogen dependent conditions
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
Lemay et al. Possible luteolytic effects of luteinizing hormone-releasing hormone in normal women
KR890701117A (ko) 무시할 정도의 히스타민을 방출하는 루테인화 호르몬 방출 호르몬의 효과있는 길항체
DK0741744T3 (da) Immunogener mod gonadeotropinfrigørende hormon
ATE319736T1 (de) In position 5 und 6 modifizierte gonadotropin freisetzendes hormon (gnrh)-antagonisten
NZ511131A (en) Estrogen agonists/antagonists and cGMP elevators for treating female sexual dysfunction
IT1197570B (it) Miscele di fsh e lh da ipofisi porcine in rapporto definito
IT8022519A0 (it) Derivati nonapeptide e decapeptide dell'ormone che rilascia l'ormone luteinizzante.
TR200003063T2 (tr) Üreme bozukluklarının tedavisi
JP2002512975A5 (de)
BE838657A (fr) Induction de l'ovulation au moyen de la gonadotrophine chorionique humaine partiellement desialylee
RU2000129658A (ru) Способ терапевтического лечения бесплодия
ATE65407T1 (de) Verfahren zur herbeifuehrung der ovulation.
Bosu et al. Effect of HCG on plasma levels of estrogens and progesterone during the luteal phase of the menstrual cycle in rhesus monkeys (Macaca mulatta). Stimulation of sex steroid production in rhesus monkeys
EP0788799A3 (de) LHRH-Antagoniste für Behandlung von Fruchtbarkeitsstörungen
BG101158A (en) Establishment of tonic overial secretion of estrogen for continuous therapeutical regimen
DE69923988D1 (de) Gedächnissverbesserung durch verabreichung von delta-5-androsten-3-beta-ol-7,17-dion und 3-beta-estern desselben
AR024438A1 (es) Antagonista hormonal liberador de gonadotropina
Ulker et al. LHRH antagonist decreases LH and progesterone secretion but does not alter length of estrous cycle in heifers
Gossage et al. The role of gonadotrophin releasing hormone in the investigation and treatment of hypogonadism.
Labhsetwar Prostaglandins and catecholamines in gonadotropin secretion

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0994718

Country of ref document: EP